India Pharma Outlook Team | Friday, 16 February 2024
Getinge, a global leader in medical technology, has announced the launch of its new Servo-c machine in the Indian market. Servo-c is designed to meet the diverse respiratory needs of pediatric and adult patients and provides a lung-preserving medical device. This launch is important in bringing advanced healthcare solutions to hospitals across India.
As healthcare costs rise, there is a growing need to invest in sustainable, safe, high-quality solutions. Building on 50 years of Servo work, Getingeand's Servo-c aims to simplify respiratory support, giving hospitals in India access to the latest equipment at an affordable price. Commenting on the launch, Aruna Nayak, Managing Director of Getinge India, said:
"In the intensive care sector, the focus is reducing the risk in the patient's emergency breathing process. From flow ventilation to weaning, Servo-c offers a seamless transition to achieve optimal patient outcomes. Adjust the workflow. Our commitment is to provide innovative solutions that fit the healthcare environment and its evolving needs. Servo-c will improve respiratory care in India and self-care in intensive care units. It will give and simplify your workflow. Servo-c is essential for safe, easy, and effective use as it enables personalized delivery of materials for respiratory therapy.
Features such as CO2 monitoring and Servo Compass allow visualization of volume and pressure targets, providing reverse and real-time visibility to lung machines and ventilators. Aruna Nayak emphasized the importance of Servo-c in the Indian healthcare scenario. She said, "Our goal is to support healthcare professionals in India by providing them with tools that ICUs must continue to run and serve patients confidently."
Getinge provides hospitals and life sciences organizations with products and solutions to improve clinical outcomes and optimize workflows. Its offerings include products and solutions for critical care, cardiac procedures, operating rooms, aseptic processing and life sciences.